Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage

Autoimmunity

Volumn 33, Issue 2, 2001, Pages 115-120

  Torn C ^a   Landin Olsson, M ^a   Lernmark, A ^a   Schersten B ^a   Ostman J ^a   Arnqvist, H J ^a   Bjork E ^a   Blohme G ^a   Bolinder, J ^a   Eriksson, J ^a   Littorin, B ^a   Nystrom L ^a   Sundkvist, G ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Beta cell function; GADA; IA 2A; ICA

Indexed keywords

AUTOANTIBODY; C PEPTIDE; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; CELL DAMAGE; CELL FUNCTION; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SWEDEN;

EID: 0035073980     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916930108995996     Document Type: Article

References (18)

1. Autoantigens IA-2A and GAD in Type 1 (insulin-dependent) diabetes
2. Type 1 diabetes
3. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity
4. Autoantibodies associated with pre-symptomatic insulin-dependent diabetes mellitus in women
5. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies
6. Immunological heterogeneity in Type 1 diabetes: Presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease
7. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes
8. World Health Organization Technical Report Series No 727
9. Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15-34 years
10. Prolonged incubation in the two-colour immunoflourescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus
11. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in Type 1 diabetes
12. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
13. 3H recombinant human ligands
14. ICA512 autoantibody radioassay
15. Predictability of C-peptide for autoimmune diabetes in young adult diabetic patients
16. Autoantibodies in relation to residual insulin secretion in children with IDDM
17. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes
18. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency